Piperidine derivatives and their use to treat obesity, diabetes, dyslipidemia and atherosclerosis

Details for Australian Patent Application No. 2010277622 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Ackermann, Jean; Conte, Aurelia; Hunziker, Daniel; Neidhart, Werner; Nettekoven, Matthias; Wertheimer, Stanley

Agent Spruson & Ferguson

Pub. Number AU-A-2010277622

PCT Pub. Number WO2011/012602

Priority 09166846.7 30.07.09 EP

Filing date 27 July 2010

Wipo publication date 3 February 2011

International Classifications

C07D 211/44 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4436 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/012602 Priority application(s): WO2011/012602

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010277627-Energy management in a building

2010277620-Ring-annulated dihydropyrrolo(2,l-a)isoquinolines